Skip to main content
PODD
NASDAQ Life Sciences

CEO Warns of Slower 2027 Growth as Rivals Threaten Omnipod Share

Tom Rudovsky · Reported by Benzinga
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$162.265
Mkt Cap
$11.262B
52W Low
$126.4
52W High
$354.88
52W Position info
28% above low
Off High info
54% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

PODD sits 28% above its 52-week low of $126.4.

Summary

CEO Ashley McEvoy told the Q3 call that Insulet will take a more conservative view of 2027, with revenue growth slowing as the base gets larger, Omnipod 6 launches, and new insulin pump competitors enter. She conceded rivals could take a few percentage points of market share. That forward caution is the negative offset to an otherwise strong quarter reported earlier today: revenue of $842M (+19.2%) beat the high end of guidance, adjusted EPS of $1.99 beat the $1.59 estimate, and the company raised the low end of FY26 revenue guidance to $3.277B while lifting its adjusted operating margin outlook to about 150bps of expansion. The board also approved a $1 billion buyback, with roughly $400M expected in Q4 funded from existing cash. The stock gained Wednesday on the results, but the 2027 share-loss commentary is the first explicit management acknowledgment that the competitive moat is narrowing.

At the time of this announcement, PODD was trading at $162.27 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.3B. The 52-week trading range was $126.40 to $354.88. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

PODD - Latest Insights

PODD
Nov 04, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $165.02
Real-time Price: $156.12 info
Change: -$8.90 (-5%) info
Market Cap: $10.828B info
PODD
Nov 04, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $155.77
Real-time Price: $156.12 info
Change: +$0.350 (+0.22%) info
Market Cap: $10.828B info
PODD
Nov 04, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $155.77
Real-time Price: $156.12 info
Change: +$0.350 (+0.22%) info
Market Cap: $10.828B info
PODD
Aug 05, 2026, 8:01 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $144.52
Real-time Price: $156.12 info
Change: +$11.60 (+8%) info
Market Cap: $10.828B info
PODD
Aug 05, 2026, 7:04 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $147.60
Real-time Price: $156.12 info
Change: +$8.52 (+6%) info
Market Cap: $10.828B info